tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS

Compare Coherus Biosciences (CHRS) vs. Competitors

1,659 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Coherus Biosciences
$1.65
$247.32M
-1.00
107.81%
4 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$4.11
$906.89M
-18.84
350.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
Protalix
$2.28
$183.70M
-21.41
-2.56%
1 Buy
0 Hold
0 Sell
Moderate Buy
Seres Therapeutics
$8.71
$83.50M
-2.15
-18.75%
1 Buy
1 Hold
0 Sell
Moderate Buy
Innate Pharma
$1.45
$128.34M
-1.23
-20.11%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CHRS
Coherus Biosciences
1.65
0.91
122.37%
SLS
SELLAS Life Sciences Group
5.05
3.94
354.95%
PLX
Protalix
2.28
-0.03
-1.30%
MCRB
Seres Therapeutics
8.71
-2.90
-24.99%
GNFT
IPHA
Innate Pharma
1.45
-0.37
-20.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts